≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hypertrophy of (infrapatellar) fat pad

DOID EFO Endpoint Browser PheWeb

M13_FATPADHYPERTROPHY

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M79.4
  • Hospital discharge: ICD-9 — 7293A
  • Cause of death: ICD-10 — M79.4
  • Cause of death: ICD-9 — 7293A

2 out of 7 registries used, show all original rules.

387

4. Check minimum number of events

None

387

5. Include endpoints

None

387

6. Filter based on genotype QC (FinnGen only)

387

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M79
Name in latin
Hypertrophia corporis adiposi infrapatellaris

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2650 1415 1223
Only index persons 2524 1364 1160
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.05 0.05 0.04
Median age at first event (years)
Whole population 38.04 39.91 35.86
Only index persons 37.48 39.43 35.19

-FinnGen-

Key figures

All Female Male
Number of individuals 387 232 155
Unadjusted period prevalence (%) 0.07 0.08 0.07
Median age at first event (years) 37.97 36.40 40.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
369
Matched controls
3689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M79.4
ICD-10 Finland
Hypertrophy of (infrapatellar) fat pad
+∞
309.7
252
*
7293A
ICD-9 Finland
Other disorders of soft tissues, Panniculitis, unspecified[LIPOSYNOVITIS INFRAPATELLARIS (MORBUS HOFFA)]
+∞
131.2
118
*
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
67.9
66.9
76
14
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
14.5
53.7
95
86
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
6.9
35.8
98
183
1225
FHL
Arthroscopy and other therapeutic procedure
23.8
33.6
48
23
M23.8
ICD-10 Finland
Other internal derangements of knee
14.8
32.9
56
44
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
13.9
29.3
51
42
M79.6
ICD-10 Finland
Pain in limb
3.9
28.6
150
550
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
5.3
26.1
87
201
M25.5
ICD-10 Finland
Pain in joint
3.7
25.9
144
543
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.2
25.0
207
1047
1222
FHL
Arthroscopy and synovial surgery
33.6
24.1
31
10
M01AH05
ATC
etoricoxib; oral
3.1
22.9
255
1544
M17.1
ICD-10 Finland
Other primary gonarthrosis
4.2
22.2
95
281
N02AX02
ATC
tramadol; systemic, rectal
3.0
21.1
172
829
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.3
21.1
86
242
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
28.9
20.3
27
10
N03AX16
ATC
pregabalin; oral
3.6
19.9
104
360
1220
FHL
Arthroscopy
8.2
19.4
44
60
SPAT1153
SPAT
Removal of sutures
3.0
18.5
136
601
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.1
17.8
120
498
M79.0
ICD-10 Finland
Rheumatism, unspecified
38.8
17.8
22
6
SPAT1249
SPAT
Treatment-related counselling outside office
2.7
17.6
176
933
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
25.5
17.5
24
10
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.7
16.5
49
97
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
12.6
14.8
26
22
R01AD12
ATC
fluticasone furoate; nasal
2.6
14.4
142
725
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.4
13.6
51
130
SPAT1260
SPAT
Consultation of another employee
3.1
13.3
79
294
SPAT1312
SPAT
General health counselling
2.5
13.2
135
698
WX320
NOMESCO Finland
Spinalanesthesy
2.8
13.2
96
408
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
5.9
12.9
36
66
SPAT1263
SPAT
Sampling
2.3
12.3
161
934
M01AB05
ATC
diclofenac; systemic, rectal
2.3
12.2
266
1946
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
18.8
12.2
18
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
12.1
158
913
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.2
11.9
67
239
M01AC06
ATC
meloxicam; systemic, rectal
2.3
11.9
143
790
M03BX02
ATC
tizanidine; oral
2.2
11.8
247
1760
H02AB06
ATC
prednisolone; systemic
2.2
11.7
176
1079
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
11.7
137
748
N03AX12
ATC
gabapentin; oral
3.3
11.7
61
207
1221
FHL
Arthroscopy and meniscus surgery
7.9
11.6
26
35
M70.6
ICD-10 Finland
Trochanteric bursitis
4.3
11.5
43
109
M22.4
ICD-10 Finland
Chondromalacia patellae
6.9
11.5
28
43
M02AA07
ATC
piroxicam; topical
2.3
11.3
131
708
S83.2
ICD-10 Finland
Tear of meniscus, current
4.1
11.3
45
122
M01AX05
ATC
glucosamine; oral
2.9
11.1
74
295
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.9
11.1
46
129
A02BC02
ATC
pantoprazole; systemic
2.1
11.1
238
1692
N06AX21
ATC
duloxetine; oral
3.5
11.0
52
163
J01FA10
ATC
azithromycin; systemic
2.1
10.8
231
1626
M01AE02
ATC
naproxen; oral, rectal
2.1
10.8
219
1510
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
8.4
10.8
23
29
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.9
10.6
34
74
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
10.6
54
180
M67.4
ICD-10 Finland
Ganglion
8.1
10.5
23
30
G54.0
ICD-10 Finland
Brachial plexus disorders
9.2
10.4
21
24
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
7.8
10.3
23
31
HAHOM
NOMESCO Finland
NA
13.6
10.2
17
13
A02BC01
ATC
omeprazole; systemic
2.4
10.2
103
518
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.2
10.2
56
195
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
10.1
79
345
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
10.0
109
566
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.9
9.9
40
110
R06.0
ICD-10 Finland
Dyspnoea
2.5
9.8
83
380
M54.5
ICD-10 Finland
Low back pain
2.2
9.7
123
683
L08
ICPC
Shoulder symptom/complaint
2.8
9.7
66
267
M54.4
ICD-10 Finland
Lumbago with sciatica
2.8
9.6
66
268
J01AA02
ATC
doxycycline; systemic
2.2
9.6
287
2266
D82
ICPC
Teeth/gum disease
2.1
9.6
141
839
M01AX17
ATC
nimesulide; oral
2.4
9.5
90
433
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
9.5
145
873
R01AD08
ATC
fluticasone; nasal
2.2
9.5
115
629
SPAT1301
SPAT
No procedures
2.2
9.4
116
638
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.4
9.3
46
149
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
9.3
67
280
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
9.2
111
604
L15
ICPC
Knee symptom/complaint
2.5
8.9
73
327
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.9
8.8
55
210
M02AA10
ATC
ketoprofen; topical
2.8
8.8
59
236
M03BC51
ATC
orphenadrine, combinations; systemic
2.1
8.8
114
638
M47.82
ICD-10 Finland
Other spondylosis, cervical region
6.9
8.8
21
32
R53
ICD-10 Finland
Malaise and fatigue
2.4
8.7
77
360
SPAT1211
SPAT
Application of soft bandage
3.5
8.7
40
123
N02BE01
ATC
paracetamol; systemic, rectal
2.3
8.7
309
2558
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
5.9
8.6
23
41
XF404
NOMESCO Finland
Ambulatory ECG
3.7
8.6
37
108
WX402
NOMESCO Finland
General anaesthesia
2.4
8.6
78
369
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
8.5
35
98
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
8.5
141
869
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.1
8.5
32
83
M09AX01
ATC
hyaluronic acid; parenteral
6.1
8.4
22
38
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.0
8.4
26
55
S06.0
ICD-10 Finland
Concussion
3.4
8.4
40
127
M79.7
ICD-10 Finland
Fibromyalgia
11.1
8.4
15
14
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
8.4
8
*
J01FA09
ATC
clarithromycin; systemic
2.0
8.3
125
738
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
8.3
42
139
N06AA09
ATC
amitriptyline; systemic
3.4
8.3
40
128
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
8.2
132
803
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
17.6
8.1
12
7
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
8.1
51
196
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
5.0
8.1
25
53
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
8.0
85
432
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
13.4
7.9
13
10
M79.1
ICD-10 Finland
Myalgia
2.8
7.9
50
193
J01DB01
ATC
cefalexin; oral
2.1
7.9
300
2481
R51.80
ICD-10 Finland
Headache
2.6
7.8
58
243
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
45.9
7.7
9
*
N05BA01
ATC
diazepam; systemic, rectal
2.8
7.7
51
201
9242
FHL
Other reconstruction or plastic surgery of shoulder joint (including ac joint)
25.6
7.6
10
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.7
7.5
31
88
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
7.4
165
1116
M01AB08
ATC
etodolac; oral
3.7
7.4
31
89
M01AE01
ATC
ibuprofen; systemic, rectal
2.5
7.4
336
2951
L13
ICPC
Hip symptom/complaint
2.8
7.4
49
193
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
7.4
36
117
XA402
NOMESCO Finland
ENMG
9.6
7.3
14
15
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
7.3
70
336
SPAT1310
SPAT
Counselling related to known health issue
2.0
7.3
112
664
7261X
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]
+∞
7.3
7
*
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
+∞
7.3
7
*
WX723
NOMESCO Finland
CPAP therapy
4.0
7.2
28
75
M54.2
ICD-10 Finland
Cervicalgia
3.6
7.2
31
91
UDC00
NOMESCO Finland
Ear microscopy
3.2
7.1
36
120
1223
FHL
Arthroscopy and articular cartilage surgery
10.3
7.1
13
13
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.2
7.1
16
23
R52.2
ICD-10 Finland
Other chronic pain
7.2
7.1
16
23
R06AE07
ATC
cetirizine; oral
1.8
7.1
160
1087
M01AH01
ATC
celecoxib; oral (coxibs)
2.4
7.0
62
288
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.9
7.0
41
151
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
7.0
30
88
Z01.9
ICD-10 Finland
Special examination, unspecified
3.8
6.9
28
78
M23
ICD-10 Finland
Internal derangement of knee
8.5
6.9
14
17
M48.0
ICD-10 Finland
Spinal stenosis
3.2
6.8
34
113
R03AC02
ATC
salbutamol; inhalant
1.8
6.8
184
1319
SPAT1097
SPAT
Recording of ECG
2.6
6.8
50
212
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
6.7
96
550
A02BA02
ATC
ranitidine; systemic
2.3
6.7
66
321
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
6.7
140
919
R05
ICPC
Cough
2.1
6.6
80
431
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
7.0
6.6
15
22
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
6.5
57
264
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.9
6.5
17
30
M01AH02
ATC
rofecoxib; oral
2.7
6.5
44
175
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
14.6
6.4
10
7
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
14.6
6.4
10
7
WX110
NOMESCO Finland
Local anesthesy
1.8
6.4
251
2001
SPAT1377
SPAT
Polysomnography
4.3
6.4
22
53
G47.3
ICD-10 Finland
Sleep apnoea
2.1
6.4
80
434
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.8
6.4
41
160
M65.3
ICD-10 Finland
Trigger finger
9.5
6.3
12
13
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
6.3
36
130
XX9TE
NOMESCO Finland
Compementary ultrasound examination
18.4
6.3
9
5
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
6.3
83
461
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
6.3
27
80
N05CF01
ATC
zopiclone; oral
1.9
6.3
104
627
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
+∞
6.3
6
*
SPAT1281
SPAT
Other administrative function
2.9
6.3
36
131
NGF20
NOMESCO Finland
Operation for osteochondritis of knee, open
27.1
6.2
8
*
M89.0
ICD-10 Finland
Algoneurodystrophy
27.1
6.2
8
*
M23.4
ICD-10 Finland
Loose body in knee
27.1
6.2
8
*
7188E
ICD-9 Finland
Other derangement of joint, Other joint derangement, not elsewhere classified[MB ARTICULI, LIGAM ET CARTILAG AL DEF,LONKKANIVEL]
27.1
6.2
8
*
H02BX01
ATC
methylprednisolone, combinations; systemic
4.8
6.2
19
41
NG1DA
NOMESCO Finland
X-ray of knees
7.9
6.2
13
17
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.5
6.1
20
46

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761536) Microorganisms panel - Urine sediment
139
242
8.40
83.09
3.6
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
121
262
6.26
56.65
3.5
2.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
93
205
5.66
41.80
4.4
3.5
mmol/l
1.2
1.2
0.45
84
185
(3029937) Albumin [Presence] in Urine by Test strip
184
716
3.99
39.50
3.9
3.2
estimate
0.0
0.0
0.50
109
261
(3021589) Normoblasts [#/volume] in Blood
262
1348
3.92
36.00
14.1
8.6
e9/l
0.0
0.0
0.59
250
1117
(3012501) Base excess in Blood by calculation
42
45
10.35
35.99
4.2
2.3
mmol/l
2.6
2.8
0.14
30
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
47
9.64
33.39
3.8
3.3
%
57.8
55.1
0.51
41
47
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
44
9.74
32.11
3.8
3.2
e9/l
3.9
4.2
0.40
39
44
(3028271) Lactate [Moles/volume] in Capillary blood
34
34
10.87
30.47
2.0
1.9
mmol/l
1.6
1.7
0.24
34
34
(40760892) CBC W Ordered Manual Differential panel - Blood
169
717
3.41
30.14
6.5
4.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
47
8.86
29.11
2.6
2.4
%
16.4
16.5
0.03
14
29
(3041096) Erythrocytes [Presence] in Urine by Automated
176
838
3.02
24.73
3.4
2.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
77
225
4.02
23.64
3.6
4.3
%
0.2
0.7
1.36
12
53
(3021440) Promyelocytes/100 leukocytes in Blood
77
227
3.99
23.33
3.7
4.6
%
0.1
0.1
0.10
15
69
(3025159) Blasts/100 leukocytes in Blood
75
217
4.05
23.32
3.7
4.6
%
0.0
0.2
0.82
12
59
(3017181) Myelocytes/100 leukocytes in Blood
79
250
3.71
21.52
3.8
4.4
%
0.7
0.9
0.24
17
81
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
205
1119
2.77
21.48
3.8
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
57
6.44
19.85
1.6
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
180
973
2.59
18.49
4.5
3.0
ng/l
14.4
27.9
3.42
116
597
(3035350) Ketones [Presence] in Urine by Test strip
226
1412
2.44
16.32
3.7
2.9
estimate
0.0
0.0
0.00
112
270
(3009261) Glucose [Presence] in Urine by Test strip
228
1434
2.44
16.17
3.7
3.0
estimate
0.0
0.0
0.00
111
260
(3021601) Nitrite [Presence] in Urine by Test strip
225
1419
2.40
15.68
4.3
4.1
estimate
0.0
0.0
0.50
111
269
(3000850) Epithelial cells [#/volume] in Urine
113
527
2.62
15.27
2.6
2.2
e6/l
6.0
7.3
0.28
101
460
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
12
12.96
15.22
1.9
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
48
5.97
14.82
4.7
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
13
11.96
14.50
1.9
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
161
902
2.34
14.44
6.7
6.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
175
1020
2.31
14.26
11.8
6.7
inr
1.1
1.2
1.11
124
331
(3013707) Erythrocyte sedimentation rate by Westergren method
295
2159
2.54
13.88
5.5
3.5
mm/h
11.1
10.5
0.34
267
1997
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
14
11.11
13.83
1.9
1.5
—
—
—
0
0
(3013512) EKG study
136
744
2.28
12.56
3.6
3.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
19
8.74
12.45
2.1
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
101
490
2.44
12.26
2.9
2.5
mosm/kgh2o
491.9
567.4
2.80
92
414
(3037522) Nuclear Ab [Titer] in Serum
82
362
2.61
12.14
1.3
1.3
titre
462.9
470.0
0.01
14
72
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
93
438
2.48
12.02
1.3
1.2
u/ml
1.3
16.3
2.59
44
177
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
131
723
2.23
11.71
2.3
2.1
u/l
110.8
274.6
1.11
115
680
(3015377) Calcium [Moles/volume] in Serum or Plasma
152
906
2.12
11.05
2.6
3.6
mmol/l
2.4
2.4
0.17
140
822
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
107
555
2.28
11.02
2.1
1.7
pmol/l
236905180.4
8299171.9
0.71
84
482
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
93
462
2.33
10.55
1.3
1.2
iu/ml
25.2
34.6
0.52
28
141
(3021788) Differential panel - Synovial fluid
20
38
5.50
10.22
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
18
8.03
10.20
1.4
1.1
u/ml
11.9
0.1
—
5
7
(36304419) Bacteria [Presence] in Urine
123
707
2.08
9.61
2.6
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
125
723
2.08
9.61
2.7
2.6
e6/l
1.1
0.4
0.41
97
531
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
30
5.88
9.35
1.7
2.1
pg
31.6
34.3
1.48
17
30
(3018418) pH of Serum or Plasma
132
788
2.02
9.25
6.2
4.0
ph
7.4
7.4
0.55
79
148
(1761868) Lipid panel - Serum or Plasma
198
1362
1.93
9.14
3.4
2.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
74
353
2.36
9.12
1.4
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
206
1439
1.92
9.05
7.0
6.0
e9/l
0.0
0.0
0.01
190
1258
(3022096) Basophils/100 leukocytes in Blood
193
1321
1.92
9.00
6.6
6.0
%
0.7
0.7
0.29
183
1237
(3001604) Monocytes [#/volume] in Blood
204
1430
1.90
8.77
7.1
6.0
e9/l
0.6
0.6
0.04
190
1249
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
36
5.20
8.70
2.1
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
208
1474
1.89
8.58
7.2
6.0
e9/l
1.9
2.0
0.31
195
1316
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
29
5.71
8.57
2.1
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
209
1486
1.88
8.51
7.0
6.5
e9/l
0.2
0.2
0.30
193
1322
(3012565) Volume of 24 hour Urine
12
16
7.71
8.46
3.0
3.2
ml
1812.5
2096.9
0.32
12
16
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
285
2262
1.99
8.07
9.7
7.0
u/l
74.9
76.1
0.26
269
2127
(3006504) Eosinophils/100 leukocytes in Blood
194
1370
1.83
7.86
6.6
5.9
%
2.9
2.8
0.42
184
1284
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
48
4.34
7.83
3.7
2.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
194
1375
1.82
7.72
6.7
6.2
%
8.4
8.6
0.38
185
1299
(3024561) Albumin [Mass/volume] in Serum or Plasma
166
1123
1.84
7.69
5.0
5.1
g/l
35.6
36.3
0.92
151
1063
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
145
945
1.85
7.54
3.1
2.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
228
1705
1.82
7.53
9.4
9.7
e9/l
4.3
4.0
0.69
211
1501
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
37
4.76
7.47
1.9
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
294
2385
1.97
7.46
4.8
3.8
pmol/l
14.9
14.6
0.85
262
2185
(3018010) Neutrophils/100 leukocytes in Blood
195
1395
1.80
7.43
5.8
5.8
%
56.2
56.8
0.31
184
1318
(3002030) Lymphocytes/100 leukocytes in Blood
198
1424
1.80
7.41
6.7
6.0
%
28.8
28.9
0.01
188
1340
(3002582) Erythrocytes [#/volume] in Urine
127
798
1.88
7.38
2.9
2.7
e6/l
68.3
182.8
0.62
101
602
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
42
4.45
7.29
2.1
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
324
2731
2.14
7.23
18.4
14.2
%
13.5
13.6
0.51
318
2678
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
355
3126
2.64
6.83
18.4
11.1
mg/l
16.1
22.7
4.19
302
2389
(3018095) Leukocytes [#/volume] in Urine
144
961
1.79
6.78
3.1
3.2
e6/l
98.6
66.6
0.24
112
654
(3025941) Bacteria identified in Stool by Culture
38
153
2.65
6.67
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
616
1.89
6.60
2.2
1.7
mg/l
0.6
1.1
5.63
83
470
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
345
3012
2.34
6.55
15.6
10.1
ml/min/173m2
86.5
85.5
0.47
313
2442
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
38
4.35
6.34
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
253
2008
1.75
6.28
4.1
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
44
4.00
6.05
1.9
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
267
2165
1.75
6.00
4.9
3.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
59
3.52
5.94
1.3
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
146
2.54
5.73
2.8
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
163
1170
1.68
5.69
6.5
6.4
mmol/l
1.2
1.2
0.16
149
1083
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
48
3.66
5.38
2.0
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
71
406
1.92
5.35
2.4
1.7
nmol/l
1503.3
1193.0
2.15
52
311
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
179
1336
1.63
5.25
4.5
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
77
455
1.86
5.24
3.2
3.0
mmol/l
2.4
2.4
0.19
66
411
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
125
854
1.68
5.16
2.8
2.3
u/l
50.7
58.2
1.88
109
801
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
56
3.32
4.95
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
63
3.12
4.74
2.1
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
227
2.06
4.42
1.1
1.3
iu/ml
66.9
151.2
1.50
13
101
(3023103) Potassium [Moles/volume] in Serum or Plasma
353
3215
2.12
4.33
17.3
12.7
mmol/l
4.0
4.0
1.64
346
3117
(3019550) Sodium [Moles/volume] in Serum or Plasma
352
3204
2.09
4.30
17.2
12.6
mmol/l
139.6
139.7
0.32
344
3113
(3026493) Urate [Moles/volume] in Serum or Plasma
106
723
1.64
4.30
2.3
2.5
umol/l
331.4
10065.1
4.21
86
636
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
67
2.93
4.29
2.1
1.8
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
31
3.96
4.29
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
36
3.70
4.24
3.2
2.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
22
87
2.62
4.04
1.7
1.3
g/l
1.1
1.2
0.94
22
80
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
323
2885
1.72
3.87
5.4
4.4
mu/l
2.0
1.9
0.23
294
2655
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
63
384
1.77
3.84
2.1
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
21
85
2.55
3.70
1.7
1.3
g/l
0.2
0.2
0.84
21
79
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
368
3440
2.42
3.67
12.5
8.9
u/l
26.4
27.0
0.32
356
3333
(3022145) Colonoscopy Study observation
54
319
1.81
3.66
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
94
648
1.60
3.60
6.2
4.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
47
3.05
3.44
2.8
2.1
g/l
128.7
132.7
0.17
14
38
(40760888) Immunoglobulin light chains.free panel - Serum
14
47
3.05
3.44
3.7
4.6
—
—
—
0
0
(3002256) Pathology report gross observation
58
360
1.72
3.32
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
56
345
1.73
3.29
2.2
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
104
2.29
3.22
1.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
111
2.24
3.20
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
93
657
1.55
3.18
1.4
1.3
u/ml
0.6
1.9
1.32
46
189
(3023520) Reticulocytes [#/volume] in Blood
35
189
1.94
3.13
2.9
2.6
e9/l
79.9
70.0
0.58
28
142
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
90
633
1.55
3.13
2.5
2.0
mg/l
3.3
2.9
0.97
72
542
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
164
1308
1.44
3.06
6.3
7.3
mmol/l
1.2
1.2
0.17
92
1117
(3021901) Oxygen saturation in Capillary blood
14
51
2.81
3.02
2.8
2.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
40
230
1.82
2.97
2.9
2.0
nmol/l
13.8
13.6
0.06
34
212
(46235355) HIV 1 and 2 tests - Meaningful Use set
91
650
1.52
2.94
1.7
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
359
3364
1.93
2.90
19.0
10.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
169
1368
1.42
2.85
3.7
2.6
ug/l
111.5
102.9
0.29
149
1273
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
85
2.30
2.75
2.3
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
176
1445
1.40
2.70
8.1
6.4
umol/l
9.1
10.7
3.49
160
1370
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
255
2231
1.42
2.69
3.7
2.9
u/l
43.8
45.5
0.16
233
2119
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
85
610
1.50
2.68
4.1
3.3
ng/l
859.1
1147.9
0.37
69
506
(40768795) Lymph node Pathology biopsy report
10
32
3.18
2.66
1.3
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
74
2.36
2.62
1.5
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
43
263
1.71
2.61
1.9
1.8
—
—
—
0
0
(44813793)
8
20
4.06
2.58
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
7
7.22
2.55
1.0
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
6
11
5.52
2.55
1.5
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
11
5.52
2.55
4.2
5.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
69
2.38
2.52
3.4
3.7
mg/l
17.5
33.1
—
6
56
(3035637) Corticotropin [Mass/volume] in Plasma
9
26
3.52
2.49
1.1
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
63
2.44
2.49
1.7
1.5
mg/l
383.7
436.5
0.33
15
58
(3004789) Transferrin [Mass/volume] in Serum or Plasma
56
372
1.59
2.49
3.4
2.3
g/l
2.4
2.4
0.01
51
347
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
21
3.87
2.47
1.6
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
17
342
0.47
2.43
3.3
4.0
%
34.2
31.5
0.58
12
234
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
27
3.39
2.40
1.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
148
1198
1.38
2.40
1.8
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
84
2.20
2.38
1.9
1.6
—
0.0
—
0
16
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
42
264
1.66
2.32
1.8
1.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
13
4.67
2.28
4.5
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
151
1.85
2.22
1.0
1.1
—
106.0
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
61
2.34
2.17
1.2
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
61
2.34
2.17
1.1
1.3
u/ml
456.8
237.6
—
8
36
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
19
3.73
2.16
1.0
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
377
3635
2.44
2.15
24.9
16.7
e9/l
255.9
253.5
0.32
371
3545
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
68
2.25
2.14
3.5
3.7
—
1.2
—
0
8
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
131
1.89
2.13
1.5
1.3
mu/l
365.3
307.2
0.27
18
119
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
141
1152
1.35
2.11
2.7
2.2
nmol/l
80.2
73.8
2.04
132
1060
(3048689) Calprotectin [Mass/mass] in Stool
52
354
1.54
2.09
3.2
2.3
ug/g
114.5
129.9
0.20
39
289
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
249
2216
1.35
2.08
3.0
3.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
10
5.05
2.07
1.0
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
377
3639
2.39
2.07
25.0
16.7
e12/l
4.5
4.6
0.75
371
3542
(3034860) Kappa light chains.free [Mass/volume] in Serum
15
69
2.22
2.07
3.6
3.7
mg/l
38.3
58.9
—
5
56
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
389
1.51
2.06
1.9
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
98
758
1.39
2.05
2.9
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
58
0.00
2.05
0.0
2.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
377
3640
2.38
2.05
25.0
16.7
e9/l
6.8
6.6
1.11
371
3543
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
186
1.72
2.04
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
103
805
1.38
2.03
1.6
1.6
mmol/l
1.4
1.4
0.05
62
683
(4062490)
8
26
3.12
2.02
2.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
26
3.12
2.02
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
17
84
2.07
1.98
4.7
4.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
51
2.40
1.97
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
64
2.23
1.96
2.1
2.0
ug/min
169.7
140.1
—
9
38
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
71
2.16
1.95
2.9
2.6
mmol/l
26.0
25.1
0.45
15
60
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
27
3.00
1.94
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
33
2.77
1.94
1.7
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
16
3.79
1.94
6.2
7.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
362
1.50
1.90
1.5
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
22
3.22
1.89
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
28
2.90
1.87
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
311
2887
1.39
1.83
5.3
4.9
mmol/mol
38.7
39.1
0.29
270
2710
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
11
47
2.38
1.79
6.2
5.0
u/ml
126.9
180.2
0.17
11
42
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
48
333
1.50
1.79
3.7
2.4
%
24.4
24.1
0.04
43
287
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
613
1.38
1.76
1.8
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
12
54
2.26
1.75
1.7
1.4
e6/l
4564.9
9650.6
—
7
40
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
18
3.37
1.75
1.5
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
70
525
1.41
1.75
1.6
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
5
13
3.88
1.72
1.2
2.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
13
3.88
1.72
1.2
1.1
miu/ml
1703.4
1439.2
—
5
13
(3022948) Iron [Moles/volume] in Serum or Plasma
55
396
1.45
1.71
3.5
2.3
umol/l
13.9
13.8
0.03
49
371
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
660
0.69
1.64
2.6
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
57
2.14
1.56
1.0
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
71
2.01
1.56
1.9
2.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
170
1.63
1.53
1.3
1.4
iu/l
22.9
26.3
0.25
21
155
(3000494) Fungus identified in Specimen by Culture
47
336
1.45
1.53
1.5
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
27
2.62
1.52
1.1
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
27
2.62
1.52
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
38
262
1.50
1.48
2.2
2.4
%
1.9
1.8
0.24
32
244
(3007164) IgA [Mass/volume] in Serum or Plasma
78
613
1.34
1.47
1.5
1.4
g/l
2.4
2.3
0.47
60
409
(3007853) Bacteria identified in Skin by Aerobe culture
44
314
1.45
1.45
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
66
2.00
1.45
1.1
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
2.8
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
351
1.42
1.40
1.5
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
89
1.83
1.39
1.3
1.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
17
2.97
1.36
1.6
1.4
mmol/l
1.6
2.0
—
5
17
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
17
2.97
1.36
1.4
2.8
%
153.6
125.5
—
5
17
(3049717) Cytology report of Urine Cyto stain
14
76
1.87
1.31
2.1
2.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
34
2.38
1.30
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
107
1.72
1.28
2.0
2.0
u/l
153.1
2247.8
—
9
48
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
36
2.25
1.25
1.6
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
103
861
1.27
1.23
3.0
3.2
mmol/l
8.8
7.9
0.76
72
746
(40768800) Prostate Pathology biopsy report
10
49
2.07
1.23
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
37
2.19
1.22
1.0
1.2
pmol/l
171.1
333.9
—
8
31
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
379
0.66
1.22
1.7
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
490
0.71
1.18
3.5
3.5
ng/l
27.7
339.9
3.37
24
357
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
3.6
—
7.5
—
0
34
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
20
2.52
1.15
1.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
20
2.52
1.15
1.6
4.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
168
1.52
1.13
1.5
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
57
717
0.76
1.12
5.0
3.7
%
92.3
93.6
0.14
50
697
(3000492) Spirometry study
42
314
1.38
1.11
1.4
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
81
1.76
1.10
1.4
1.3
ug/g
227.0
324.0
—
6
46
(40761535) Cells panel - Urine sediment
27
186
1.49
1.09
3.4
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
21
2.40
1.09
2.2
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
229
1.43
1.08
1.7
2.5
ml/min/173m2
69.4
70.2
0.03
16
88
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
46
1.98
1.04
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
60
1.86
1.04
1.7
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
22
2.29
1.03
1.0
1.1
—
5.3
—
0
5
(40768443) Skin Pathology biopsy report
18
115
1.59
1.01
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
131
0.53
1.00
4.9
15.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
49
1.86
0.99
1.1
1.2
—
1.0
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
191
1.44
0.97
1.5
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
54
1.87
0.97
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
255
0.65
0.94
1.4
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
12
70
1.74
0.93
2.8
4.6
mmol/l
1.2
1.3
0.09
12
70
(3019060) Gas panel - Arterial blood
22
151
1.48
0.92
3.6
8.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
107
927
1.21
0.92
1.7
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
118
1033
1.20
0.91
4.8
3.4
u/l
32.0
31.4
0.06
107
993
(3000330) Specific gravity of Urine by Test strip
7
127
0.54
0.90
3.0
3.0
—
—
—
0
0
(4035726)
33
247
1.37
0.89
2.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
161
1.46
0.89
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
43
1.88
0.88
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
91
780
1.22
0.87
3.1
3.2
mg/l
78.4
317.0
0.91
51
506
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
30
2.02
0.87
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
137
1.48
0.86
1.8
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
323
3104
1.25
0.85
4.1
3.9
mmol/l
5.9
5.8
0.19
292
2874
(3027008) Opiates [Presence] in Urine
20
138
1.47
0.83
1.8
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
138
1.47
0.83
1.8
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
87
746
1.21
0.83
6.0
6.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
89
1.59
0.82
2.9
3.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
32
1.89
0.82
3.5
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
47
1.72
0.81
1.1
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
95
824
1.20
0.81
5.1
4.0
mg/mmol
12.8
10.1
0.14
54
529
(3028300) Cannabinoids [Presence] in Urine
20
139
1.46
0.81
1.8
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
125
0.55
0.79
1.0
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
67
1.66
0.76
2.0
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
50
408
1.26
0.75
2.5
2.3
s
29.8
29.5
0.15
50
396
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
323
3116
1.22
0.74
3.8
3.6
mmol/l
1.4
1.3
1.43
290
2928
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
53
437
1.25
0.74
2.0
1.8
%
1.4
1.4
0.06
44
388
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
25
2.01
0.73
1.2
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
61
720
0.82
0.72
3.5
3.8
%
17.2
21.2
1.42
28
296
(36660697) Celiac disease serology panel - Serum
16
228
0.69
0.72
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
126
1.45
0.71
1.7
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
417
0.77
0.70
2.8
2.6
e6/l
3.3
2.6
0.19
16
223
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
41
1.72
0.70
2.3
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
127
1.44
0.69
1.8
2.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
153
1.39
0.68
4.2
3.6
mmol/l
2.7
1.8
0.76
15
116
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
178
0.66
0.66
1.8
1.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
2.2
3.9
u/ml
23.2
58.7
—
5
29
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
49
1.65
0.62
1.4
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
51
1.58
0.61
1.4
1.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
20
0.00
0.60
0.0
9.3
—
53.5
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
231
0.72
0.60
1.6
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
22
0.00
0.59
0.0
1.1
—
12.6
—
0
22
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
112
0.62
0.59
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
113
0.61
0.59
6.3
3.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
97
868
1.16
0.58
4.5
4.2
ug/l
2.1
2.4
0.14
83
794
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
44
367
1.22
0.57
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
107
1.42
0.56
1.9
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
82
1.48
0.55
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
21
160
1.33
0.55
4.4
3.5
ph
7.4
7.4
1.62
13
24
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
390
1.20
0.52
2.1
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
135
1.35
0.52
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
84
1.44
0.50
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
106
0.65
0.49
2.4
2.0
—
—
—
0
0
(3019225) pH of Specimen
19
242
0.77
0.46
2.3
4.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
49
1.44
0.46
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
229
1.24
0.45
1.9
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
51
1.38
0.44
1.3
1.1
—
12.9
—
0
5
(40768793) Breast Pathology biopsy report
11
78
1.42
0.43
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
56
1.44
0.43
1.0
1.0
—
—
—
0
0
(44790049)
5
33
1.52
0.41
1.2
2.0
—
—
—
0
0
(44790048)
5
33
1.52
0.41
1.2
2.0
—
—
—
0
0
(44806118)
5
33
1.52
0.41
1.2
2.0
—
—
—
0
0
(44790047)
5
33
1.52
0.41
1.2
2.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.7
—
109.9
—
0
15
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
178.1
—
0
15
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
18
141
1.29
0.41
5.6
11.2
mmol/l
26.1
24.7
0.98
18
132
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
81
889
0.89
0.40
2.4
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
37
1.36
0.37
1.0
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
67
605
1.13
0.37
1.4
1.4
nmol/l
19.3
21.0
0.31
56
519
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
330
3236
1.13
0.35
4.3
4.0
mmol/l
4.8
4.8
0.24
298
3064
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
42
1.44
0.35
2.2
2.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
435
1.14
0.35
2.2
2.0
—
—
—
0
0
(4094501)
6
87
0.68
0.33
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
334
3282
1.13
0.32
4.6
4.4
mmol/l
2.9
2.9
0.01
302
3080
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
328
3221
1.12
0.31
4.3
4.0
mmol/l
1.5
1.5
0.04
294
3027
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
98
0.71
0.31
2.0
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
100
0.69
0.31
4.6
11.7
%
1.9
1.7
—
7
95
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
606
0.89
0.30
4.3
3.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
41
460
0.88
0.30
1.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
311
3052
1.10
0.27
12.8
12.3
%
41.1
40.7
0.50
205
2375
(3023511) Choriogonadotropin [Units/volume] in Urine
8
64
1.26
0.27
1.5
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
445
0.89
0.26
2.1
2.4
e6/l
1.9
1.0
0.51
21
251
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
132
1.22
0.26
1.6
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
213
0.84
0.25
5.3
9.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
76
1.19
0.25
1.7
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
84
0.71
0.24
1.0
1.1
—
—
—
0
0
(4010399)
18
211
0.85
0.23
1.5
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
39
1.29
0.23
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
39
1.29
0.23
1.4
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
315
1.12
0.22
9.0
5.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
2.3
—
61.5
—
0
12
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
530
0.91
0.20
2.7
2.7
ug/l
0.6
0.7
1.36
30
313
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
99
1.22
0.20
1.8
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
53
1.13
0.19
2.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
19
167
1.14
0.17
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
33
302
1.10
0.16
4.0
2.7
umol/l
5.6
6.8
0.37
23
259
(3005033) Fetal Nuchal fold Thickness US
11
92
1.20
0.16
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
93
1.19
0.14
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
17
191
0.89
0.14
3.0
3.3
e9/l
3.8
4.1
0.25
12
165
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
106
1023
1.05
0.14
1.7
1.8
pmol/l
92.2
94.2
0.19
61
561
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
95
1.16
0.11
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
48
1.04
0.09
2.6
1.7
%
12.6
13.0
—
5
48
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
155
1.10
0.09
1.1
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
144
0.90
0.08
3.3
9.7
%
0.8
0.7
0.62
13
144
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
144
0.90
0.08
3.3
9.4
%
1.4
1.5
0.04
13
144
(3028707) Methadone [Presence] in Urine by Screen method
6
58
1.04
0.08
1.7
2.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
16
146
1.10
0.08
3.0
2.4
e6/l
0.0
0.2
1.83
16
137
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
65
0.77
0.08
1.2
1.8
nmol/l
0.8
0.8
—
5
53
(3012544) pH of Venous blood
23
246
0.93
0.08
4.6
4.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
123
0.89
0.08
1.1
1.4
miu/ml
197.6
254.7
—
6
61
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
196
1.08
0.07
2.8
4.3
ng/l
78.4
79.6
0.03
15
182
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
94
0.85
0.06
1.8
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
132
0.91
0.06
1.2
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
102
0.88
0.06
1.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
105
0.85
0.06
1.8
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
121
0.91
0.06
1.5
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
13
140
0.93
0.04
3.4
10.0
%
92.1
94.0
0.31
13
140
(3022621) pH of Urine by Test strip
17
160
1.07
0.04
2.1
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
26
271
0.96
0.04
3.8
10.3
mmol/l
2.2
1.4
0.98
21
219
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
240
1.04
0.03
1.2
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
589
1.02
0.03
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
112
1.07
0.03
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
112
1.07
0.03
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
113
1.06
0.02
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
113
1.06
0.02
1.4
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
127
0.94
0.01
3.7
2.4
%
1.2
1.2
0.02
12
127
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
124
1.05
0.00
1.7
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
59
592
1.00
0.00
4.4
3.0
kg/l
1.0
1.0
—
6
84
(4034850)
10
97
1.03
0.00
7.6
6.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
55
0.91
0.00
1.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
74
0.94
0.00
1.4
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
79
0.88
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.3
—
1.2
—
0
6
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
72.0
—
0
7
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
1.7
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
57.5
—
0
5
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
9
0.00
0.00
0.0
1.6
—
78.9
—
0
9
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
49
1.02
0.00
1.2
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.6
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
85
0.94
0.00
1.5
1.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
52
0.96
-0.00
1.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_FATPADHYPERTROPHY and mortality.

Females

Parameter HR [95% CI] p-value
M13_FATPADHYPERTROPHY 1.243 [0.99, 1.57] 0.065
Birth year 0.993 [0.98, 1.0] 0.123

During the follow-up period (1.1.1998 — 31.12.2019), 97 out of 968 females with M13_FATPADHYPERTROPHY died.

Males

Parameter HR [95% CI] p-value
M13_FATPADHYPERTROPHY 1.002 [0.78, 1.29] 0.987
Birth year 0.99 [0.98, 1.0] 0.092

During the follow-up period (1.1.1998 — 31.12.2019), 68 out of 711 males with M13_FATPADHYPERTROPHY died.

Mortality risk

Mortality risk for people of age

years, who have M13_FATPADHYPERTROPHY.

N-year risk Females Males
1 0.089% 0.239%
5 0.548% 1.293%
10 1.615% 3.128%
15 3.274% 6.069%
20 5.57% 10.718%

Relationships between endpoints

↥

Index endpoint: M13_FATPADHYPERTROPHY – Hypertrophy of (infrapatellar) fat pad

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data